Gastrointestinal Infection Testing Market

Global Market Study on Gastrointestinal Infection Testing: Surge in Use of Sophisticated Infection Detection Panels in Bacterial GI Testing Anticipated to Push Growth

Gastrointestinal Infection Testing Market Segmented By Bacterial Strains, Viral Strains, and Parasitic Disease Strains with Reagent Kits, Sequencing Kits, and Equipment Product Type

Industry: Healthcare

Published Date: May-2022

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 213

Report ID: PMRREP17314

Report Price

$ 4900*

Buy Now

Gastrointestinal Infection Testing Market Outlook (2022 - 2026)

Infections of the gastrointestinal tract are among the most prevalent ones in primary care. Gastrointestinal infection testing is done to detect bacteria, viruses, and parasites. The rising prevalence of digestive disorders and gastrointestinal infections is likely to drive the gastrointestinal infection testing market over the forecast period. At a CAGR of 4.9%, the Global Gastrointestinal Infection Testing Market is estimated to reach $490.2 million by 2026.

Attribute Key Insights

Gastrointestinal Infection Testing Market Size (2022)

US$ 404.5 Mn

Projected Market Value (2026)

US$ 490.2 Mn

Global Market Growth Rate (2022-2026)

4.9% CAGR

Share in parent market

1.4%

Gastrointestinal Infection Testing Market Demand Analysis (2013-2021) v/s Market Outlook (2022-2026)

The rising frequency of abdominal discomfort triggered by gastrointestinal infection associated with the viral, parasitic, or bacterial infections is propelling the Gastrointestinal Infection Testing Market. Furthermore, rising digestive problems as a result of poor eating habits will drive growth in the worldwide gastrointestinal infection testing market.

Key Drivers to the Gastrointestinal Infection Testing Market

  • Increasing Prevalence of Gastrointestinal Infections

The global gastrointestinal infection testing market is rapidly expanding, as an increasing number of people suffer from gastrointestinal infections caused by viruses, parasites, or bacteria. Increased digestion-related ailments and gastrointestinal infections due to poor dietary habits will drive expansion in the global gastrointestinal infection testing market. The growing patient population is likely to raise demand for improved gastrointestinal infection testing solutions. As a result, the increased prevalence of gastrointestinal infections is a primary driver of the gastrointestinal infection testing market's expansion.

gastrointestinal-infection-testing-market

  • Technological Advancements in Gastrointestinal Infection Testing Solutions

The technological development of gastrointestinal infection testing equipment is another factor that is projected to boost the global gastrointestinal infection testing market. New technological advancements have resulted in the development of new gastrointestinal infection testing solutions that can identify infectious pathogens such as bacteria, viruses, and parasites in a timely manner. The increasing requirement for precise and rapid detection of infectious pathogens is driving researchers and manufacturers to develop new testing solutions, which will drive market growth in the near future.

Restraints to the Gastrointestinal Infection Testing Market

  • “Improper Regulatory Guidelines and Lack of Awareness”

The Global Gastrointestinal Infection Testing Market is projected to witness a CAGR of 4.9% during the forecast period, although factors such as a lack of regulatory guidelines and a lack of understanding of advanced molecular diagnostic techniques may hinder the market growth. Furthermore, inadequate sanitation facilities, lack of sufficient medical facilities, and unsanitary conduct of people, particularly in emerging nations, would stifle growth in this market.

Impact of Covid-19 Pandemic

“Decreased Demand for Gastrointestinal Infection Testing”

As COVID-19 cases began to peak in 2020, lockdowns were implemented in many parts of the world, which resulted in decrease in gastrointestinal infection testing globally. Reductions in laboratory-confirmed cases were seen across all the age groups and both sexes, with regional differences in diagnostic patterns reported. However, in 2021, when the Covid-19 restrictions were relaxed, the Gastrointestinal Infection Testing frequency began to rise.

Competitive Landscape

The Gastrointestinal Infection Testing Market is moderately competitive, with both - domestic and foreign players present, and it is dominated by global giants. Emerging players in the Gastrointestinal Infection Testing market are working on new organic and inorganic tactics to increase their product footprint in the global Gastrointestinal Infection Testing market.

Gastrointestinal Infection Testing Market Industry Report Scope

Attribute Details

Forecast Period

2022-2026

Historical Data Available for

2013-2021

Market Analysis

US$ Mn/Bn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Countries Covered

  • U.S.
  • Canada
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Russia
  • India
  • China
  • Japan
  • UAE
  • Australia

Key Market Segments Covered

By End User

Key Companies Profiled

  • Becton, Dickinson and Company (BD)
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Luminex Corporation
  • Hoffmann-La Roche Ltd.
  • bioMérieux SA
  • Quidel Corporation
  • Illumina, Inc.
  • Seegene Inc
  • Genetic Signatures

Customization & Pricing

Available upon Request

Gastrointestinal Infection Testing Market Categorization

Gastrointestinal Infection Testing Market by End User

  • Hospitals
  • Clinics/Medical Centers
  • Diagnostic Laboratories
  • Research Institutes

Gastrointestinal Infection Testing Market by Disease Strains

  • Bacterial Strains
  • Viral Strains
  • Parasitic Strains

Gastrointestinal Infection Testing Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • Becton, Dickinson and Company (BD)
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Luminex Corporation
  • Hoffmann-La Roche Ltd.
  • bioMérieux SA
  • Quidel Corporation
  • Illumina, Inc.
  • Seegene Inc
  • Genetic Signatures

Frequently Asked Questions

In 2022, the Gastrointestinal Infection Testing Market stands at USD 404.5 million, and it is expected to reach USD 490.2 million by 2026 at a CAGR of 4.9%.

Gastrointestinal Infection Testing Market exhibited a CAGR of 4.8% between 2013 and 2021.

Improper regulatory guidelines and lack of awareness are the key restraints in the Gastrointestinal Infection Testing Market.

Increasing Prevalence of Gastrointestinal Infections is the key factor driving the growth of the market.

Becton, Dickinson & Company (BD), Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., and Luminex Corporation are among the top players in the market.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate